| Issue |
Section |
Title |
File |
| Vol 16, No 4 (2017) |
Статьи |
Blinatumomab therapy for relapsed and refractory acute lymphoblastic leukemia |
(Rus)
|
| Vol 16, No 4 (2017) |
Статьи |
The nutritional status and efficiency of different types of nutritional support in patients with non-Hodgkin's lymphomas (NHL) in active phase of treatment |
(Rus)
|
| Vol 17, No 1 (2018) |
Статьи |
Intrachromosomal amplification of chromosome 21 (iAMP21) is the marker of unfavorable prognosis in childhood B-cell precursor acute lymphoblastic leukemia |
(Rus)
|
| Vol 16, No 2 (2017) |
Статьи |
Atypical pulmonary metastases in children with conventional osteosarcoma |
(Rus)
|
| Vol 16, No 2 (2017) |
Статьи |
Organization of medical care for children with hematological diseases |
(Rus)
|
| Vol 16, No 3 (2017) |
Статьи |
The results of pilot trial ALL-REZ-MВ-2014 for children with relapsed acute lymphoblastic leukemia |
(Rus)
|
| Vol 14, No 1 (2015) |
ОСТРЫЙ ЛИМФОБЛАСТНЫЙ ЛЕЙКОЗ |
Comparative analysis of dexamethasone and methylprednisolone efficacy in induction therapy of childhood acute lymphoblastic leukemia: Results of ALL-MB 2002 multicenter study |
(Rus)
|
| Vol 14, No 1 (2015) |
ОСТРЫЙ ЛИМФОБЛАСТНЫЙ ЛЕЙКОЗ |
Therapy of childhood T-cell acute lymphoblastic leukemia: Experience gained by the Russian-Byelorussian cooperative group |
(Rus)
|
| Vol 17, No 4 (2018) |
ORIGINAL ARTICLES |
Hhe results of different antibodies application for CD1a expression evaluation in pediatric t-lineage all |
(Rus)
|
| Vol 18, No 1 (2019) |
PROMISING STUDIES |
First results of pilot protocol ALl-REZ-2016 for children with high risk groups of relapsed acute lymphoblastic leukemia |
(Rus)
|
| Vol 18, No 1 (2019) |
ORGANIZATION OF HEALTHCARE |
Difficulties of the federal centers providing the profile medical assistance |
(Rus)
|
| Vol 18, No 2 (2019) |
ORIGINAL ARTICLES |
The thoracic air-leak syndrome (TALS): the frequency of occurrence and radiological signs in the structure of late non-infectious lung lesions in children after the allogeneic HSСT |
(Rus)
|
| Vol 18, No 4 (2019) |
LITERATURE REVIEW |
Osteosarcoma with lung metastases |
(Rus)
|
| Vol 19, No 4 (2020) |
CLINICAL OBSERVATIONS |
Challenges in the diagnosis of growing teratoma syndrome: two case reports |
(Rus)
|
| Vol 21, No 1 (2022) |
ORIGINAL ARTICLES |
The outcomes of children with acute myeloid leukemia treated in accordance with the AML–MM-2006 protocol |
(Rus)
|
| Vol 21, No 3 (2022) |
ORIGINAL ARTICLES |
High-risk acute lymphoblastic leukemia in the ALL-MB 2002 study |
(Rus)
|
| Vol 21, No 3 (2022) |
CLINICAL OBSERVATIONS |
Acute lymphoblastic leukemia with the t(17;19) translocation: hope has appeared! Multimodal immunotherapy in a 3-year-old child with refractory disease: a case report |
(Rus)
|
| Vol 21, No 4 (2022) |
ORIGINAL ARTICLES |
Efficacy and safety of low doses of olanzapine for the prevention of nausea and vomiting in children and adolescents receiving highly emetogenic chemotherapy. The interim results of a randomized trial |
(Rus)
|
| Vol 22, No 1 (2023) |
ORIGINAL ARTICLES |
The use of inotuzumab ozogamicin in children with relapsed/refractory B-lineage acute lymphoblastic leukemia |
(Rus)
|
| Vol 22, No 1 (2023) |
ORIGINAL ARTICLES |
The role of blinatumomab in the treatment of B-cell relapses of acute lymphoblastic leukemia in children: own experience |
(Rus)
|
| Vol 22, No 3 (2023) |
ORIGINAL ARTICLES |
Quantitative bone marrow magnetic resonance imaging in children with lymphoblastic leukaemia |
(Rus)
|
| Vol 22, No 4 (2023) |
ORIGINAL ARTICLES |
Flow cytometric and cytomorphological definition of remission achievement in children with B-lineage acute lymphoblastic leukemia |
(Rus)
|
| Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
Bispecific monoclonal antibody blinatumomab in the first-line therapy of B-lineage acute lymphoblastic leukemia in children and adolescents: interim results of the Russian Ministry of Health approbation protocol |
(Rus)
|
| Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
Tolerability and toxicity of induction chemoimmunotherapy with dinutuximab beta in newly diagnosed patients with high-risk neuroblastoma |
(Rus)
|
| Vol 23, No 1 (2024) |
CLINICAL OBSERVATIONS |
Immune checkpoint inhibitor therapy in children and adolescents with refractory/relapsed Hodgkin lymphoma: a case series |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
Pegylated asparaginase during induction therapy in children with intermediate-risk acute lymphoblastic leukemia: results of a randomized study |
(Rus)
|
